Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
psychopharmacology-bulletin
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Psychopharmacology Bulletin Subscription – Individual
$
225.00
/ year
Subscribe Now
Details
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
Peter H. Canter, PhD, BSc: Ginkgo Biloba: A Smart Drug? A Systematic Review of Controlled Trials of the Cognitive Effects of Ginkgo Biloba Extracts in Healthy People
$
30.00
Add to cart
Details
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
$
30.00
Add to cart
Details
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
$
30.00
Add to cart
Details
Aliza P. Wingo – Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients
$
30.00
Add to cart
Details
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
$
30.00
Add to cart
Details
Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
$
30.00
Add to cart
Details
Phebe Tucker, MD: Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Jose M. Canive, MD: Efficacy of Olanzapine and Risperidone in Schizophrenia: A Randomized Double-Blind Crossover Design
$
30.00
Add to cart
Details
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Paul E. Holtzheimer III, MD: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
$
30.00
Add to cart
Details
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
Ross A. Baker – Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
$
30.00
Add to cart
Details
Efficacy of Omega-3 Fatty Acids in Mood Disorders
$
30.00
Add to cart
Details
Sanjay J. Mathew, MD: Management of Treatment-Refractory Panic Disorder
$
30.00
Add to cart
Details
K. Ranga R. Krishnan, MD: Informant-Rated Cognitive Symptoms in Normal Aging, Mild Cognitive Impairment, and Dementia
$
30.00
Add to cart
Details
Jennifer L. Donovan, PhD: A Primer on Caffeine Pharmacology and Its Drug Interactions in Clinical Psychopharmacology
$
30.00
Add to cart
Details
Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
George Harrison, MD: Priapism and Quetiapine: A Case Report
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Comparing the Methods Used to Compare Antidepressants
$
30.00
Add to cart
Details
Madhukar H. Trivedi – Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
$
30.00
Add to cart
Details
Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
$
30.00
Add to cart
Details
Use of Lamotrigine for Bipolar Disorder in Pregnancy and Breastfeeding
$
30.00
Add to cart
Details
Assessing Rates and Predictors of Tachyphylaxis
$
30.00
Add to cart
Details
Catatonia and CPK Elevation in Neurosyphilis
$
30.00
Add to cart
Details
1
2
…
5
Next
Page load link
Go to Top
